GlassScriptPhysician profile
Meghan L Hurt
NPI 1679863591
$2,827.69
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $701 · 2021: $937 · 2022: $267 · 2023: $340 · 2024: $62.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $540.05 | 2019-2023 | |
| Daiichi Sankyo INC. | $391.74 | 2019-2021 | |
| Coopersurgical, INC. | $314.39 | 2019-2023 | Paragard T 380a |
| Pfizer INC. | $182.60 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $173.85 | 2019-2023 | |
| Avion Pharmaceuticals | $132.56 | 2019-2022 | |
| Therapeuticsmd, INC. | $119.98 | 2020-2022 | |
| Hologic Sales and Service, LLC | $110.05 | 2020-2024 | Aptima, Thinprep 2000 Processor, Third Wave |
| Allergan, INC. | $84.62 | 2019-2020 | |
| Exeltis, USA INC. | $79.60 | 2020-2023 | Slynd |
| Amgen INC. | $72.73 | 2019-2021 | |
| Evofem Biosciences, INC. | $65.22 | 2020-2021 | |
| Astellas Pharma US INC | $57.00 | 2023-2024 | Veozah, Myrbetriq |
| Agile Therapeutics, INC. | $56.73 | 2021 | |
| Mayne Pharma Commercial LLC | $46.56 | 2021-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $45.51 | 2019-2021 | |
| Myovant Sciences INC. | $44.04 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $38.97 | 2019-2020 | |
| Medtronic, INC. | $38.32 | 2021 | |
| Organon LLC | $35.61 | 2022-2023 | Nexplanon |
| Lupin INC. | $29.19 | 2019-2020 | |
| Davol INC. | $28.18 | 2023 | Arista Ah Flexitip |
| Amag Pharmaceuticals, INC. | $25.30 | 2019 | |
| Ascend Therapeutics US, LLC | $22.94 | 2020 | |
| Sumitomo Pharma America, INC. | $19.12 | 2023 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $16.31 | 2021 | |
| Scynexis, INC. | $15.58 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.00 | 2019 | |
| Exact Sciences Corporation | $14.48 | 2023 | Cologuard Collection Kit |
| Covidien LP | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Hurt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.